Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study to standardize glucose-dependent insulin secretion assessment in type 2 diabetes
NL-OMON36208Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of insulin aspart and glucose in type 2 diabetes mellitus (T2DM), sponsored by PRA Health Sciences. Primary endpoints: Methodology standardization, Pharmacodynamics and 2 more. Started Feb 2011; status: active, not recruiting.
02
Drugs
insulin aspartglucose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON36208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36208.